Concerto Biosciences announces discovery initiative to combat recurrent vaginal yeast infections with novel live microbial product

Ensemble No.3 (ENS-003) is in development to address vulvovaginal candidiasis – a vaginal yeast infection for which antifungal treatments offer limited protection from recurrence.

How next generation probiotics will accelerate precision medicine

Microbiomepost interviewed Lorenzo Drago, from University of Milan, during the ESGE DAYS congress, held recently in Dublin.

Lifestyle may influence how gut bacteria are shared between mothers and infants

The findings of a recent study suggest that lifestyle can influence how bacterial strains are shared between mothers and infants.

Gut microbes may be linked to bone loss during spaceflight

The findings of a recent study suggest that changes to the gut microbiotas in space may be associated with a loss of bone density.

GC Genome’s New Study Reveals Link Between Gut Microbiome and High Blood Pressure

A large Korean population study provides scientific evidence that altering the gut microbiome composition through dietary habit change can help prevent and manage the hypertension.

Chr. Hansen secures EU approval for the final HMO in its 5 HMO Mix

The 6’-SL HMO from Chr. Hansen is approved for highest use levels in infant formula and follow-on formula in EU.

Adaptive evolution of Staphylococcus aureus in atopic dermatitis patients

A recent study highlights the importance of evaluating microbes’ mutations in understanding the contribution of microbes to complex diseases.

Study reveals previously unknown viruses that populate the healthy infant gut

The findings of a recent study offer new insights into the diversity of the human virome and provide a resource that may help future research into the viruses that populate…

Discovering Wellmicro: pioneering breakthroughs in microbiome analysis for human health

Andrea Castagnetti, Antonella Padella and Matteo Soverini tell us about the activities and innovations of Wellmicro, the Italian company specializing in microbiota testing.

Biocodex becomes the sole shareholder of TargEDys

The French family company has acquired 100% of TargEDys’ shares, to consolidate the group’s strong ambition in the Microbiome and accelerate TargEDys’ development globally.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top